ACE and atrial fibrillation: AF patients on angiotensin-converting enzyme inhibitors (ACEI) had slightly lower NAP-2 concentrations compared to those who did not use these agents (607 [424–770] vs. 656 [488–812] ng/ml, p = 0.022).